A group of coming decisions could provide important insights into how flexible the agency is willing to be under new leadership.
5 FDA decisions to watch in the third quarter of 2026
A group of coming decisions could provide important insights into how flexible the agency is willing to be under new leadership.
Source: BioPharma Dive